Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,615.60
(
0.23%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
102.50
(
0.38%
)
Bitcoin
77,426.93
(
0.07%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: Protector post# 280898

Saturday, 12/10/2016 8:57:05 AM

Saturday, December 10, 2016 8:57:05 AM

Post# of 347009
Regarding Avid
https://lifesciences.knect365.com/bioprocessinternational/agenda/2

Another anomaly is that Peter Gagnon up for presentation "two times" and I like it ....certainly Better Faster Cheaper stands out and out of 9 Peregrine/Avid profiles under the PAV list of Peter Gagnon I find one Amgen profile.....and very interesting, especially since I previously found David Mee of Amgen has all 10 of his PAV ALL Peregrine/Avid profiles

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote